ΩTB® is a Universal Drug Resistance Test for TB
A single test for simultaneous evaluation of all resistance markers, as well as the differentiation between mixed infection, relapse and reinfection
Comparing ΩTB® (Omega TB) with current tests
Drug Analysis
- ΩTB®
- Culture Test
- CBNAAT
- LPA
Antibiotic Coverage
- 18 antibiotics including bedaquiline and delamanid
- 13 - 15 antibiotics
- 1 - 2 antibiotics
- Targeted for first line or second line
Benefits of ΩTB®
Comprehensive
DR profile of 18 drugs, Mixed infections and Co-infections incl NTM
Validated
Tested and validated on >10,000 genomes and >1000 clinical samples
Accurate
High sensitivity and specificity comparable to molecular methods
Affordable
Test cost less than or comparable to culture testing